Research suggests that Brahmi (Centella asiatica / Gotu Kola) may possess neuroprotective properties relevant to cognitive function, with review literature noting potential anti-inflammatory, antioxidant, and cognitive-enhancing effects from its bioactive compounds. The available evidence here is limited to a single 2021 narrative or systematic review examining herbal approaches to cognitive decline and Alzheimer's disease, which is a relatively weak evidence base from which to draw firm conclusions. While the review frames herbal remedies as a promising area of investigation — particularly given the high failure rate of conventional pharmaceutical candidates — it does not itself provide direct clinical trial data on Centella asiatica's effects in human subjects. Readers should be aware that a single review, however thorough, cannot establish efficacy, and that independent randomized controlled trials and meta-analyses specific to this herb and cognitive outcomes would be needed to more confidently assess its role.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Neuroprotective Herbs for the Management of Alzheimer's Disease. | Review | 2021 | Supports | 100 |